Press Releases

Mithra Signs an LOI for the Japanese and ASEAN Rights on Estetrol in Women’s Health with the Market Leader in Japan, Fuji Pharmaceuticals
24 June 2016
EN FR

Mithra Pharmaceuticals to Host Investor Day Event on June 29th, 2016 in Brussels
25 May 2016
EN FR NL

Inauguration of the Mithra CDMO on September 30, 2016, Three Months Ahead of Schedule ; a Milestone That Bodes Well for GMP Approvals
18 May 2016
EN FR

Mithra Enrols its First 5 Patients for the Donesta® Phase II Clinical Study MIT-DO0001-C201
13 May 2016
EN FR

Mithra Launches Manufacturing of Myring First Technical and Clinical Batches
10 May 2016
EN FR

Mithra Recognized by the Scientific Community: the Contraception Journal Publishes a Scientific Article About E4 (Estetrol) FIESTA Phase II Study
4 May 2016
EN FR

Mithra’s European Advisory Board for Estelle Will Meet During the ESC Congress (European Society of Contraception) in Basel on May 4th 2016
3 May 2016
EN FR

3 Out of 5 European Countries Selected Have Fully Approved Protocol of Phase II Clinical Study Donesta®-Mit-Do001-C201. 8 Out of 9 European Countries Selected Have Fully Approved Protocol of Phase III Clinical Studies Estelle®- Mit-Es001-C301
29 April 2016
EN FR

Mithra Files Patent Applications for its Sublingual Form Based on Estetrol Thereby Extending its IP Position to Sublingual Formulations in Contraception and Menopause Until 2036
28 April 2016
EN FR

Mithra Pharmaceuticals Releases 2015 Annual Report and Invitation to its Ordinary General Shareholder’s Meeting
19 April 2016
EN FR

Annual Report 2015
19 April 2016
EN FR

Mithra Obtains Three Marketing Authorisations for its Product Tibelia®, one of Which in the United Kingdom Where it Signed a First License and Supply Agreement
13 April 2016
EN FR